Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)

Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)

10.1097/JTO.0b013e3181913e28

Saved in:

Bibliographic Details
Main Authors:	Lim, E.H., Chang, A., Tan, P., Zhang, S.-L., Li, J.-L., Yap, W.-S., Ng, A., Howe, T.-C., Tan, B.-P., Lee, Y.-S., Wong, D., Khoo, K.-L., Seto, K.-Y., Tan, L., Agasthian, T., Koong, H.-N., Tam, J., Tan, C., Caleb, M.
Other Authors:	SURGERY
Format:	Article
Published:	2011
Subjects:	Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/24184
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Be the first to leave a comment!